Medication info
Fleming Tablets 625mg (Amoxicillin·Clavulanate Potassium)

Fleming Tablets 625mg (Amoxicillin·Clavulanate Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Lightpharmtech Co., Ltd.
Appearance
White or almost white oval film-coated tablets
Packaging
40 tablets/box [4 tablets/PTPX10]
Approval status
Active

MFDS item code 201906638 · Approved 2019.09.23 · Insurance code 690301700

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections; genitourinary infections; skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined according to the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. The absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary for patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Lightpharmtech Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections; genitourinary infections; skin, bone, and dental infections

  • Acute bronchitis
  • chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
View approved original text

This medication is effective against various types of bacteria. It is used for respiratory infections such as pneumonia, bronchitis, sinusitis, otitis media, and genitourinary infections such as cystitis, urethritis, and pyelonephritis. It is also effective for treating pelvic infections, gonorrhea, boil and abscess, soft tissue infections, wound infections, osteomyelitis, and dental infections. By treating a variety of bacterial infections, it helps improve symptoms. Therefore, this medication is widely used for the treatment of various infectious diseases.

How to take

Adult dose

The dose of this medicine should be determined according to the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. The absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary for patients with creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Children: Reduce the dose in the same manner.

Precautions

This medication contains amoxicillin and clavulanate potassium as part of the beta-lactam antibiotic class. It should not be used in patients with a history of allergic reactions to these ingredients or similar penicillin antibiotics. Administration is contraindicated in those with a history of severe hypersensitivity reactions such as anaphylaxis, Stevens-Johnson syndrome, or shock. Additionally, it should be avoided in patients with viral infections such as infectious mononucleosis or lymphocytic leukemia, as there is an increased risk of rash. Patients with liver dysfunction or a history of jaundice also require caution due to the risk of recurrence. Patients with impaired liver function or severe kidney dysfunction will require dose adjustments and administration interval modifications. Those with allergic tendencies should also use this medication cautiously. Elderly patients, malnourished individuals, and those with gastrointestinal disorders accompanied by vomiting or diarrhea should exercise caution when using this medication. This medication may cause gastrointestinal symptoms such as diarrhea, vomiting, and abdominal pain. In severe cases, serious side effects such as pseudomembranous colitis may occur, and if symptoms arise, patients should immediately stop using the medication and consult a doctor. Symptoms of liver dysfunction have also been reported, particularly in men over 60 years of age or with long-term use, necessitating regular liver function tests. Rarely, severe skin reactions or hypersensitivity reactions such as anaphylactic shock may occur; if symptoms such as skin rash, itching, or difficulty breathing occur, administration should be stopped immediately and emergency treatment sought. Blood abnormalities, kidney function impairment, and central nervous system adverse reactions have also been reported, so patients should be vigilant for symptoms. This medication may interact with other drugs, so especially in patients taking anticoagulants, certain antibiotics, anti-inflammatory drugs, or anticonvulsants, it is essential to inform their physician or pharmacist. It is advisable to avoid use during the first three months of pregnancy and, during pregnancy or breastfeeding, to consider the benefits versus risks carefully before administering. Pediatric use is recommended only for children over 12 years of age or weighing over 40 kg, as there is insufficient data for younger children, requiring caution. Elderly individuals may have an increased risk of side effects due to declining physical functions, thus requiring careful dose and administration interval adjustments. This medication may affect the results of certain clinical tests, such as glucose tests, so it is crucial to inform the healthcare provider conducting the tests. In case of overdose, gastrointestinal symptoms, renal failure, and seizures may occur, and immediate medical attention is necessary for appropriate treatment. It should be stored in a sealed container to avoid moisture. It is important to maintain a cool temperature between 1 and 25 degrees Celsius while storing. This will safely preserve the effectiveness of the medication.

Side effects

Diarrhea, pseudomembranous colitis, indigestion, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, acid dyspepsia, soft stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, severe colitis with bloody stools, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, mucous membrane pemphigoid, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized pustular psoriasis, drug reaction with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, respiratory distress associated with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased secretions, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, seizures, anti-tremor activity, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B deficiency, linear IgA disease, taste disturbances, malaise, dermatitis, oral edema, stomach pain, fluid and electrolyte imbalance, rash, hyperactivity syndrome, drowsiness, decreased urine output, kidney failure, epileptic seizures, hypersensitivity shock, skin reactions, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is contained in a sealed container to prevent moisture. It is important to maintain a cool temperature between 1 and 25 degrees Celsius during storage. This way, the effectiveness of the medication can be safely preserved.

Appearance and packaging

Appearance

White or almost white oval film-coated tablets

Package unit

40 tablets/box [4 tablets/PTPX10]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.